Zentalis Pharmaceuticals Market Cap

Zentalis Pharmaceuticals has a market cap or net worth of $287.27 million as of April 29, 2026. Its market cap has increased by 254.01% in one year.

Market Cap

287.27M

Enterprise Value

80.95M

1-Year Change

254.01%

Ranking

#3576

Market Cap Chart

Since April 3, 2020, Zentalis Pharmaceuticals's market cap has decreased from $587.46M to $287.27M, a decrease of -51.10%. That is a compound annual growth rate of -11.12%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	301.46M	244.86%
Dec 31, 2025	87.41M	-59.52%
Dec 31, 2024	215.93M	-79.86%
Dec 29, 2023	1.07B	-6.72%
Dec 30, 2022	1.15B	-69.82%
Dec 31, 2021	3.81B	80.54%
Dec 31, 2020	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
LENZ Therapeutics	294.10M
Compugen	293.12M
Minerva Neurosciences	288.26M
Editas Medicine	284.81M
NovaBridge Biosciences	283.34M
AC Immune	281.73M
C4 Therapeutics	281.03M
Cellectis	280.95M

Market Cap Rankings